Company Overview - Vivos Therapeutics is a revenue stage medical technology company focused on developing and commercializing innovative diagnostic and nonsurgical treatment methods for patients with breathing and sleep issues, particularly obstructive sleep apnea (OSA) [2] - OSA is estimated to affect approximately 90 million people in the U.S. and 1 billion people worldwide, highlighting a significant market opportunity for Vivos [2] Leadership and Presentation - The fireside chat features Kirk Huntsman, CEO of Vivos Therapeutics, and Brad Amman, CFO, indicating the company's commitment to engaging with stakeholders and sharing insights about its operations [3]